FundedIQ
Health Care

Avenacy: Funding, Investors & Team (Aug 2026)

Avenacy is a rapidly growing U.S.-based specialty pharmaceutical company focused on providing critical injectable medications used to treat patients in various medically supervised settings, from acute care hospitals to outpatient clinics and physician offices. Through a rigorous and optimized selection process, the Company is building out a pipeline of high-quality FDA approved injectable products to ensure a resilient portfolio that can meet the needs of today’s dynamic drug supply chain. With an experienced team, commitment to quality and reliability, and product offerings intended to facilitate safe and efficient patient care, Avenacy strives to be a trusted partner for essential injectable medications.

www.avenacy.com LinkedIn Schaumburg, United States 11-50 employees
Manufacturing Medical Pharmaceutical
Total raised
$26.0M
Rounds
1
Latest
Undisclosed round
Nov 2024

Avenacy has raised $26.0M across 1 funding round on record, the most recent an undisclosed round of $26.0M announced in Nov 2024.

That round is above the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.

Avenacy Company Profile and Key Stats

Total funding raised
$26.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$26.0M in Nov 2024
Employees
11-50
reported band
Headquarters
Schaumburg, United States

Latest funding round on record: Nov 2024.

Avenacy Funding Rounds

Date
Round
Amount
Undisclosed round
$26.0M

Avenacy Founders and Leadership Team

Name
Role
Contact
Jeffrey Yordon
Founder
Locked

Contact details for the Avenacy team: 1 of 1 has an email address on file.

Start 14-day free trial →

Avenacy Funding Compared to Other Health Care Startups

Segment
Companies
Median round
3,653
$4.7M
29,722
$7.5M

Avenacy's latest round of $26.0M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Avenacy in Health Care and Schaumburg

Companies Similar to Avenacy

https://metriport.com

Series A $26.0M

There are too many reasons why Healthcare is unaffordable in the U.S, but one of the largest is waste. Up to…

Series A $17.0M

Serif Health provides healthcare price intelligence and contract management solution.

Private Equity $5.7M

Switchboard Health provides virtual care solutions to payers, health systems, employers, and at-risk…

Undisclosed round $5.0M

Astek Diagnostics has designed a system that helps doctors choose the right antibiotics for patients…

Seed $750k

TECLens is developing a crosslinking technology that can effectively address vision problems in both healthy…

Series A $10.0M

Healthcare Shares operates as a crowdfunding portal for the transformative medical innovations of the future.

Undisclosed round $1.5M

Gradient Health collaborates with medical data providers worldwide to assemble diseases and conditions for AI…

Undisclosed round $3.0M

Kalivir designs safe and potent oncolytic product candidates across multiple tumor types. Kalivir’s…

Series A $14.0M

Happy Health is a mission-driven technology company committed to transforming mental health awareness through…

Undisclosed round $75.0M

Leal Therapeutics creates new treatments for patients.

Series A $30.0M

Teal Health is on a mission to empower women when it comes to their health – starting with at-home cervical…

Series A $18.3M

Avenacy Funding FAQs

What does Avenacy do?

Avenacy is a rapidly growing U.S.-based specialty pharmaceutical company focused on providing critical injectable medications used to treat patients in various medically supervised settings, from acute care hospitals to outpatient clinics and physician offices. Through a rigorous and optimized selection process, the Company is building out a pipeline of high-quality FDA approved injectable products to ensure a resilient portfolio that can meet the needs of today’s dynamic drug supply chain. With an experienced team, commitment to quality and reliability, and product offerings intended to facilitate safe and efficient patient care, Avenacy strives to be a trusted partner for essential injectable medications.

How much funding has Avenacy raised?

Avenacy has raised $26.0M across 1 round on record. The most recent is an undisclosed round of $26.0M announced in Nov 2024.

When did Avenacy last raise funding?

Avenacy's most recent funding round on record is an undisclosed round of $26.0M, announced in Nov 2024.

Who founded Avenacy?

FundedIQ lists Jeffrey Yordon (Founder) at Avenacy.

Where is Avenacy headquartered?

Avenacy is based in Schaumburg, Illinois, United States.

How many employees does Avenacy have?

Avenacy is in the 11-50 employee band.

How does Avenacy's funding compare to other Health Care startups?

Avenacy's latest round of $26.0M is above the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.

About FundedIQ's Avenacy Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Avenacy is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.